The clinical manifestations of antisynthetase syndrome are severe interstitial pneumonitis, mild polyarthritis, and myositis. This disease is accompanied by anti-Jo-1 antibodies and anti-Ro/SSA antibodies and occasionally by the concurrence of anti-Jo-1 and anti-Ro/SSA antibodies, which leads to a more severe form of interstitial lung disease. In this case, the patient was transferred to our hospital because of pulmonary fibrosis with myositis and diagnosed with antisynthetase syndrome and the concurrence of anti-Jo-1 with anti-Ro/SSA antibodies. He was refractory to glucocorticoids, and developed leucopenia and thrombocytopenia. He was treated with rituximab infusions, but the interstitial pneumonitis progressed very rapidly and he died. 서 론 항합성효소 항체(anti-histidyl tRNA synthetase anti-body)가 간질성 폐렴을 동반한 염증성 근염 환자에 서 발견되는 경우를 항합성효소 항체 증후군이라고 하며, 고용량의 스테로이드 치료 등의 기존의 면역 억제 치료에 잘 반응하지 않는다고 보고되었다 (1).

